• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克隆性造血与复发性静脉血栓栓塞的关联:一项病例对照研究。

Association of clonal haematopoiesis with recurrent venous thromboembolism: A case-control study.

作者信息

Englisch Cornelia, Vostatek Rafaela, Schramm Theresa, Binder Christoph J, Pabinger Ingrid, Jäger Roland, Ay Cihan

机构信息

Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

出版信息

Br J Haematol. 2025 Jan;206(1):263-271. doi: 10.1111/bjh.19871. Epub 2024 Nov 5.

DOI:10.1111/bjh.19871
PMID:39497597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11739764/
Abstract

Venous thromboembolism (VTE) is the third most common cardiovascular disease. Clonal haematopoiesis (CH) is linked to cardiovascular disease risk, but its potential association with VTE remains poorly understood. We assessed the prevalence of CH in patients with recurrent VTE (n = 107; median age [IQR] 57 [48-63] years, 44.9% female) and matched healthy controls (n = 127; median age [IQR] 53 [45-60] years, 51.2% female) to investigate a putative association of CH with VTE risk. We detected 12 CH-associated mutations in 11 (10.3%) VTE cases and six mutations in 5 (3.9%) controls. Thus, patients with recurrent VTE tended to have higher odds of presenting with CH compared to controls (OR: 2.74, 95% CI: 0.95-9.16). Moreover, the odds of detecting CH were significantly higher in VTE cases in the subgroup of individuals without thrombophilia (OR: 4.58, 95% CI: 1.48-15.99). VTE cases with CH showed elevated platelet counts compared to cases and controls without CH (median [IQR]: 292 [254-298], 223 [198-260] and 220 [185-259] × 10/L; both p < 0.01). Fibrinogen, sP-selectin, D-dimer and hsCRP levels did not differ according to CH status. Overall, we identified a trend for an association between CH and recurrent VTE, particularly in individuals without underlying thrombophilia, warranting further research in this patient group.

摘要

静脉血栓栓塞症(VTE)是第三常见的心血管疾病。克隆性造血(CH)与心血管疾病风险相关,但其与VTE的潜在关联仍知之甚少。我们评估了复发性VTE患者(n = 107;中位年龄[四分位间距]57[48 - 63]岁,女性占44.9%)和匹配的健康对照者(n = 127;中位年龄[四分位间距]53[45 - 60]岁,女性占51.2%)中CH的患病率,以研究CH与VTE风险之间的假定关联。我们在11例(10.3%)VTE病例中检测到12个与CH相关的突变,在5例(3.9%)对照者中检测到6个突变。因此,与对照者相比,复发性VTE患者出现CH的几率更高(比值比:2.74,95%置信区间:0.95 - 9.16)。此外,在无血栓形成倾向的个体亚组中,VTE病例中检测到CH的几率显著更高(比值比:4.58,95%置信区间:1.48 - 15.99)。与无CH的病例和对照者相比,有CH的VTE病例血小板计数升高(中位数[四分位间距]:292[254 - 298]、223[198 - 260]和220[185 - 259]×10⁹/L;p均<0.01)。纤维蛋白原、可溶性P选择素、D - 二聚体和高敏C反应蛋白水平根据CH状态无差异。总体而言,我们发现CH与复发性VTE之间存在关联趋势,尤其是在无潜在血栓形成倾向的个体中,这值得在该患者群体中进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2e5/11739764/dec9301de519/BJH-206-263-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2e5/11739764/a97ad378b722/BJH-206-263-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2e5/11739764/248699c0bc37/BJH-206-263-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2e5/11739764/44ebae14009f/BJH-206-263-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2e5/11739764/dec9301de519/BJH-206-263-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2e5/11739764/a97ad378b722/BJH-206-263-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2e5/11739764/248699c0bc37/BJH-206-263-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2e5/11739764/44ebae14009f/BJH-206-263-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2e5/11739764/dec9301de519/BJH-206-263-g003.jpg

相似文献

1
Association of clonal haematopoiesis with recurrent venous thromboembolism: A case-control study.克隆性造血与复发性静脉血栓栓塞的关联:一项病例对照研究。
Br J Haematol. 2025 Jan;206(1):263-271. doi: 10.1111/bjh.19871. Epub 2024 Nov 5.
2
JAK2-mutant clonal hematopoiesis is associated with venous thromboembolism.JAK2 突变性克隆性造血与静脉血栓栓塞相关。
Blood. 2024 Nov 14;144(20):2149-2154. doi: 10.1182/blood.2024024187.
3
Thrombophilia and risk of VTE recurrence according to the age at the time of first VTE manifestation.根据首次静脉血栓栓塞症(VTE)表现时的年龄,探讨血栓形成倾向与VTE复发风险的关系。
Vasa. 2015 Jul;44(4):313-23. doi: 10.1024/0301-1526/a000447.
4
Prevalence of Hereditary Thrombophilia in Patients Older Than 75 Years With Venous Thromboembolism Referred for Thrombophilia Screening.75岁以上因静脉血栓栓塞接受遗传性易栓症筛查患者的遗传性易栓症患病率
J Gerontol A Biol Sci Med Sci. 2015 Aug;70(8):977-81. doi: 10.1093/gerona/glu240. Epub 2015 Feb 9.
5
Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study.与静脉血栓栓塞不同表现相关的血栓形成倾向基因突变:一项单中心三级研究
Clin Appl Thromb Hemost. 2018 Jan;24(1):100-106. doi: 10.1177/1076029616672585. Epub 2016 Oct 11.
6
Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow-up study.家族静脉血栓栓塞和血栓形成病史作为复发预测因素的作用:一项前瞻性随访研究。
J Thromb Haemost. 2015 Dec;13(12):2180-6. doi: 10.1111/jth.13154. Epub 2015 Oct 29.
7
Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.患者水平荟萃分析:D-二聚体检测评估不明原因静脉血栓栓塞后复发风险时,检测时机、阈值和患者年龄对其能力的影响。
Ann Intern Med. 2010 Oct 19;153(8):523-31. doi: 10.7326/0003-4819-153-8-201010190-00009.
8
Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.阿尔及利亚东部人群静脉血栓栓塞的遗传风险因素
Clin Appl Thromb Hemost. 2017 Mar;23(2):105-115. doi: 10.1177/1076029615600789. Epub 2016 Jul 10.
9
In Children with Provoked Venous Thromboembolism, Increasing Plasma Coagulability during the First 3 Months Postdiagnosis is Prognostic of Recurrence.在有诱发性静脉血栓栓塞的儿童中,诊断后前 3 个月内血浆凝固性增加与复发相关。
Thromb Haemost. 2020 May;120(5):823-831. doi: 10.1055/s-0040-1708879. Epub 2020 May 5.
10
Clonal haemopoiesis and venous thromboembolism risk.克隆性造血与静脉血栓栓塞风险。
Br J Haematol. 2025 Jan;206(1):389-390. doi: 10.1111/bjh.19893. Epub 2024 Nov 14.

引用本文的文献

1
Clonal hematopoiesis in patients with cancer and its association with risk of thrombosis and prognosis of disease.癌症患者的克隆性造血及其与血栓形成风险和疾病预后的关联。
Res Pract Thromb Haemost. 2025 May 8;9(4):102882. doi: 10.1016/j.rpth.2025.102882. eCollection 2025 May.

本文引用的文献

1
JAK2-mutant clonal hematopoiesis is associated with venous thromboembolism.JAK2 突变性克隆性造血与静脉血栓栓塞相关。
Blood. 2024 Nov 14;144(20):2149-2154. doi: 10.1182/blood.2024024187.
2
Combined Effects of Clonal Hematopoiesis and Carotid Stenosis on Cardiovascular Mortality.**标题**:克隆性造血与颈动脉狭窄对心血管死亡率的联合影响。 **摘要**:目的:探讨在一般人群中,克隆性造血(CH)与颈动脉狭窄(CS)对心血管死亡率(CVD)的联合影响。 **方法**:我们前瞻性地纳入了年龄在 50 岁及以上的参与者,他们在基线时无已知的心血管疾病,且接受了 CH (使用 ASH 2016 标准)和 CS(使用颈动脉超声)的检测。在平均 5.6 年的随访期间,记录了所有的 CVD 事件和死亡。 **结果**:在 1,702 名参与者中(平均年龄 72.7±7.6 岁;59.5%为女性),共有 205 例(12.0%)发生了 CVD 事件和 105 例(6.1%)死亡。在多变量 Cox 回归分析中,与 CH 无关的 CS(定义为狭窄程度<50%)与 CVD 事件(HR,1.36;95%CI,1.03-1.80;P=0.03)和 CVD 死亡率(HR,1.50;95%CI,1.03-2.21;P=0.03)显著相关。当 CH 被认为是一个连续变量时,CH 水平与 CVD 事件(HR,1.05;95%CI,1.02-1.08;P<0.001)和 CVD 死亡率(HR,1.05;95%CI,1.02-1.09;P<0.001)显著相关。当 CH 和 CS 同时存在时,与 CS 无关的 CH 和 CS 均与 CVD 事件(HR,1.50;95%CI,1.05-2.14;P=0.02)和 CVD 死亡率(HR,1.50;95%CI,1.04-2.18;P=0.03)显著相关。 **结论**:在一般人群中,CH 和 CS 与 CVD 事件和 CVD 死亡率显著相关,且当 CH 和 CS 同时存在时,这种相关性更强。这些发现提示,在评估 CVD 风险时,同时考虑 CH 和 CS 可能是有益的。
J Am Coll Cardiol. 2024 May 7;83(18):1717-1727. doi: 10.1016/j.jacc.2024.02.043.
3
A genomic mutational constraint map using variation in 76,156 human genomes.基于 76156 个人类基因组的变异,绘制出基因组突变约束图谱。
Nature. 2024 Jan;625(7993):92-100. doi: 10.1038/s41586-023-06045-0. Epub 2023 Dec 6.
4
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.不定潜能克隆性造血预测动脉粥样硬化性心血管疾病患者的不良结局。
J Am Coll Cardiol. 2023 May 23;81(20):1996-2009. doi: 10.1016/j.jacc.2023.03.401.
5
mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease.介导的克隆性造血会增加发生动脉粥样硬化疾病的风险。
Nat Cardiovasc Res. 2023 Jan 16;2:144-158. doi: 10.1038/s44161-022-00206-6.
6
Association of telomere length and mitochondrial DNA copy number, two biomarkers of biological aging, with the risk of venous thromboembolism.端粒长度和线粒体 DNA 拷贝数与生物衰老的两个生物标志物与静脉血栓栓塞风险的关联。
Thromb Res. 2023 Mar;223:168-173. doi: 10.1016/j.thromres.2023.01.031. Epub 2023 Feb 3.
7
Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic stroke.克隆性造血与首发缺血性脑卒中患者再发血管事件和死亡的相关性。
Blood. 2023 Feb 16;141(7):787-799. doi: 10.1182/blood.2022017661.
8
Clonal Hematopoiesis Is Associated With Higher Risk of Stroke.克隆性造血与更高的中风风险相关。
Stroke. 2022 Mar;53(3):788-797. doi: 10.1161/STROKEAHA.121.037388. Epub 2021 Nov 8.
9
Is Hematopoietic Clonality of Indetermined Potential a Risk Factor for Pulmonary Embolism?具有不确定潜能的造血克隆性是肺栓塞的危险因素吗?
TH Open. 2021 Aug 17;5(3):e338-e342. doi: 10.1055/s-0041-1733856. eCollection 2021 Jul.
10
Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?哪些患者有复发性静脉血栓栓塞(深静脉血栓形成和肺栓塞)的高风险?
Blood Adv. 2020 Nov 10;4(21):5595-5606. doi: 10.1182/bloodadvances.2020002268.